$8 million offering
$250,000 minimum investment
5 year Convertible Note with Lumea, Inc.
Yield: 16%* (12% + 30 day SOFR)
Management Fee: 2%
Carry: 20%
Preferred Return/Hurdle: 12%
Convertible at last round or next round with a 25% discount
The first fully integrated digital pathology system
General Investment Guidlines
The Lumea Private Fund is designed solely to invest in Lumea, Inc. a digital pathology company that deployed proprietary tissue handling technologies, specimen tracking, laboratory efficiency improvements, a seamless digital signout process, and added invaluable AI and genetic testing partnerships to improve the quality of practices and allows businesses to scale.
